首页|期刊导航|疑难病杂志|基于血清标志物动态变化的幽门螺杆菌阴性慢性胃炎疾病进展预测模型构建

基于血清标志物动态变化的幽门螺杆菌阴性慢性胃炎疾病进展预测模型构建OA

Construction of a predictive model for the progression of Helicobacter pylori negative chronic gastritis based on dy-namic changes in serum biomarkers

中文摘要英文摘要

目的 基于血清标志物动态变化,构建幽门螺杆菌(Hp)阴性慢性胃炎疾病进展的预测模型,为临床早期识别高风险患者、制定个体化干预策略提供依据.方法 回顾性选取 2021 年 1 月—2024 年 12 月内蒙古自治区人民医院消化内科收治的 Hp 阴性慢性胃炎患者 128 例,按疾病进展情况将患者分为疾病稳定组 96 例和疾病进展组32 例.于入组时(T0)及随访 3 个月(T1)、6 个月(T2)、12 个月(T3)时检测胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)、胃泌素-17(G-17)、白介素-6(IL-6)水平,计算各指标的变化差值及12 个月变化率;经LASSO 回归筛选Hp 阴性慢性胃炎疾病进展核心预测因子,多因素 Logistic 回归分析 Hp 阴性慢性胃炎疾病进展的影响因素并构建模型;采用受试者工作特征(ROC)曲线与校准曲线评估模型效能.结果 随访 12 个月,128 例患者疾病进展率为 25.00%(32/128).与疾病稳定组 比 较,疾病进展组年龄≥60 岁比例更高、病程更长(χ2/P=7.686/0.006,t/P=5.243/<0.001);T1~T3 时,疾病进展组血清 PGⅠ水平显著低于疾病稳定组,PG Ⅱ、G-17、IL-6 水平显著高于疾病稳定组(F/P=21.853/<0.001、43.573/<0.001、34.068/<0.001、42.497/<0.001);疾病进展组 ΔPGⅠ、ΔPGⅡ、ΔG-17、ΔIL-6 及PGⅠ、PGⅡ、G-17、IL-6 变化率均高于疾病稳定组(t/P=3.109/0.004、5.077/<0.001、6.179/<0.001、5.455/<0.001、3.132/0.003、5.538/<0.001、5.437/<0.001、6.445/<0.001);多因素 Logistic 回归分析显示,PGⅠ变化率高、PGⅡ变化率高、G-17 变化率高、IL-6变化率高为 Hp 阴性慢性胃炎疾病进展的独立危险因素[OR(95%CI)=1.213(1.031~1.426)、1.128(1.026~1.240)、1.074(1.005~1.148)、1.313(1.133~1.521)];ROC 曲线显示,模型曲线下面积为 0.934(95%CI 0.871~0.997),敏感度为 0.875,特异度为 0.958,预测概率与实际结局高度拟合.结论 基于血清 PGⅠ、PGⅡ、G-17、IL-6动态变化率构建的预测模型,可预测 Hp 阴性慢性胃炎患者疾病进展风险.

Objective To construct a predictive model for disease progression in patients with Helicobacter pylori(Hp)-negative chronic gastritis based on dynamic changes in serum biomarkers,so as to provide evidence for early identifica-tion of high-risk patients and individualized intervention strategies.Methods A total of 128 patients with Hp-negative chronic gastritis admitted to the Department of Gastroenterology,Inner Mongolia People's Hospital from January 2021 to De-cember 2024 were enrolled.According to disease progression status,the patients were divided into a disease-stable group and a disease-progression group.Serum levels of pepsinogen I(PGⅠ),pepsinogen II(PGⅡ),gastrin-17(G-17),and interleukin-6(IL-6)were measured at enrollment(T0)and at 3,6,and 12 months of follow-up(T1-T3).The absolute changes and 12-month change rates of these indicators were calculated.Lasso regression was used to screen core predictors of disease progres-sion in Hp-negative chronic gastritis,and multivariate logistic regression was performed to identify independent influencing factors and construct the predictive model.Receiver operating characteristic(ROC)curves and calibration curves were used to evaluate model performance.Results Compared with the disease-stable group,the disease-progression group had a higher proportion of patients aged≥60 years and a longer disease course(χ2/P=7.686/0.006,t/P=5.243/<0.001).At T1-T3,serum PGⅠ levels were significantly lower,while PGⅡ,G-17,and IL-6 levels were significantly higher in the disease-progression group than in the disease-stable group(F/P=21.853/<0.001,43.573/<0.001,34.068/<0.001,and 42.497/<0.001).The ΔPGⅠ,ΔPGⅡ,ΔG-17,ΔIL-6 values and their corresponding change rates were all significantly higher in the disease-progression group than in the disease-stable group(t/P=3.109/0.004,5.077/<0.001,6.179/<0.001,5.455/<0.001,3.132/0.003,5.538/<0.001,5.437/<0.001,and 6.445/<0.001).Multivariate logistic regression analysis showed that the change rates of PGⅠ,PGⅡ,G-17,and IL-6 were independent risk factors for disease progression in Hp-negative chronic gastritis[OR(95%CI)=1.213(1.031-1.426),1.128(1.026-1.240),1.074(1.005-1.148),and 1.313(1.133-1.521),respectively].ROC curve analysis showed that the area under the curve of the model was 0.934(95%CI:0.871-0.997),with a sensitivity of 87.50%and a spe-cificity of 95.83%.The predicted probabilities were highly consistent with the actual outcomes.During 12 months of follow-up,the disease progression rate among the 128 patients was 25.00%(32/128).Conclusion The predictive model constructed based on the dynamic change rates of serum PGⅠ,PGⅡ,G-17,and IL-6 can predict the risk of disease progression in pa-tients with Hp-negative chronic gastritis.

张春凤;张苗;刘峥璐

010017 呼和浩特,内蒙古自治区人民医院消化内科010017 呼和浩特,内蒙古自治区人民医院消化内科010017 呼和浩特,内蒙古自治区人民医院病理科

医药卫生

慢性胃炎幽门螺杆菌阴性血清标志物动态变化预测模型列线图

Chronic gastritisHelicobacter pylori negativeSerum biomarkersDynamic changesPredictive modelNomogram

《疑难病杂志》 2026 (9)

1055-1061,7

内蒙古自治区科技计划项目(2022YFSH0014) Inner Mongolia Autonomous Region Science and Technology Program Project(2022YFSH0014)

10.3969/j.issn.1671-6450.2026.09.006

评论